headlinez.news Live news trend intelligence
◼ Archived Business 🔮 headlinez.news predicts: still trending tomorrow — graded ✓ correct

Trump Administration Delivers Lucrative Win for Its Kratom Allies

The DEA has moved to classify the kratom compound 7-OH and related substances as Schedule I drugs, marking a significant shift in federal policy.

14sources
15articles
14velocity
+0%since first seen
46d agofirst detected
Visual summary for Trump Administration Delivers Lucrative Win for Its Kratom Allies
headlinez.news visual summary

Velocity

How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →

The brief

The Drug Enforcement Administration has filed an intent to temporarily place 7-OH and three related substances into Schedule I of the Controlled Substances Act. This regulatory action follows recent state-level crackdowns, including moves observed in California. The classification targets specific synthetic and enhanced versions of the kratom derivative.

Coverage from outlets including The New York Times, Reuters, WIRED, and The Hill highlights a tension between current administration actions and prior praise of 'natural 7-OH' attributed to President Trump. HHS and the FDA have issued statements commending the DEA’s decision to address what they describe as an 'emerging threat,' while local officials in areas like Grant County and Florida have also voiced concerns. Stakeholders are now observing how the temporary scheduling process will unfold and the extent of its impact on the broader kratom market.

Coverage does not yet specify the exact timeline for the final implementation of these controls or potential exemptions for natural derivatives.

Synthesized by headlinez.news from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 44d ago.

The reporting (15)

Quick answers

What is the DEA proposing for 7-OH?

The DEA is moving to temporarily classify 7-OH and three related substances as Schedule I controlled substances.

Which federal agencies support the move?

According to reports from HHS.gov, both the Department of Health and Human Services and the FDA have commended the DEA's action.

Has the administration addressed the policy shift?

Coverage notes that the Trump administration is under scrutiny for this policy change, specifically regarding past statements praising 'natural 7-OH'.

Topics

From around our network

Related trends